Condition
Adenoid Cystic Carcinoma of the Head and Neck
Total Trials
4
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
3Total
P 1 (1)
P 2 (2)
Trial Status
Terminated1
Unknown1
Not Yet Recruiting1
Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07579598Phase 2Not Yet RecruitingPrimary
ADC and SBRT for Recurrent/Metastatic Salivary Gland Carcinoma
NCT07507578Recruiting
A Multi-omics Approach to Disclose Progression and Underlying Biology of Head and Neck Adenoid Cystic Carcinoma
NCT05930951Phase 1TerminatedPrimary
Study of OBT076 Associated or Not in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and Neck
NCT04433169Phase 2UnknownPrimary
All-trans Retinoic Acid (ATRA) in the Treatment of Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and Neck
Showing all 4 trials